Commentary
Two Doses of Botulinum Toxin Type A for the Treatment of Trigeminal Neuralgia: Observation of Therapeutic Effect from A Randomized, Double-blind, Placebo-Controlled Trial
Haifeng Zhang and Yajun Lian*
Department of Neurology, First Affiliated Hospital of Zhengzhou University, 1 Jianshe East R, Zhengzhou City, China
- *Corresponding Author:
- Dr. Yajun Lian
Department of Neurology, First Affiliated Hospital, Zhengzhou University
1 Jianshe East R, Zhengzhou City, HeNan Province, People’s Republic of China, 450052
Tel: 86-13526659466
E-mail: lianyajun840317@163.com
Received date: June 06, 2017; Accepted date: June 19, 2017; Published date: June 22, 2017
Citation: Zhang H, Yajun Lian (2017) Two Doses of Botulinum Toxin Type A for the Treatment of Trigeminal Neuralgia: Observation of Therapeutic Effect from A Randomized, Double-blind, Placebo-Controlled Trial. Toxicol Open Access 3:128. doi: 10.4172/2476-2067.1000128
Copyright: © 2017 Zhang H, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Spanish
Chinese
Russian
German
French
Japanese
Portuguese
Hindi 